BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/23/2021 1:28:38 PM | Browse: 761 | Download: 1997
Publication Name World Journal of Cardiology
Manuscript ID 65943
Country Japan
ISSN 1949-8462 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Minireviews
Article Title Angiotensin receptor blocker neprilysin inhibitors
Manuscript Source Invited Manuscript
All Author List Daisuke Usuda, Toshihiro Higashikawa, Yuta Hotchi, Kenki Usami, Shintaro Shimozawa, Shungo Tokunaga, Ippei Osugi, Risa Katou, Sakurako Ito, Toshihiko Yoshizawa, Suguru Asako, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Jiro Oba, Tomohisa Nomura and Manabu Sugita
ORCID
Author(s) ORCID Number
Daisuke Usuda http://orcid.org/0000-0002-0059-4035
Toshihiro Higashikawa http://orcid.org/0000-0001-8690-5473
Yuta Hotchi http://orcid.org/0000-0002-5576-2956
Kenki Usami http://orcid.org/0000-0003-4023-1789
Shintaro Shimozawa http://orcid.org/0000-0001-6155-0039
Shungo Tokunaga http://orcid.org/0000-0002-7027-0984
Ippei Osugi http://orcid.org/0000-0003-4719-6373
Risa Katou http://orcid.org/0000-0001-5231-7438
Sakurako Ito http://orcid.org/0000-0001-5477-0551
Toshihiko Yoshizawa http://orcid.org/0000-0001-9700-1322
Suguru Asako http://orcid.org/0000-0002-5092-1532
Kentaro Mishima http://orcid.org/0000-0001-8674-8148
Akihiko Kondo http://orcid.org/0000-0002-3709-8000
Keiko Mizuno http://orcid.org/0000-0002-6326-6872
Hiroki Takami http://orcid.org/0000-0003-2955-3752
Takayuki Komatsu http://orcid.org/0000-0002-8730-2081
Jiro Oba http://orcid.org/0000-0001-8473-8771
Tomohisa Nomura http://orcid.org/0000-0001-5632-2584
Manabu Sugita http://orcid.org/0000-0002-1956-9286
Funding Agency and Grant Number
Corresponding Author Daisuke Usuda, MD, MSc, PhD, Doctor, Doctor, Lecturer, Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3-1-10, Takanodai, Nerima-ku 177-8521, Tokyo, Japan. d.usuda.qa@juntendo.ac.jp
Key Words Angiotensin receptor blocker and neprilysin inhibitor; Chronic heart failure; Renin-angiotensin-aldosterone-system; Sympathetic nervous system; Natriuretic peptide; Sacubitril/valsartan
Core Tip Heart failure (HF) is a multi-faceted clinical condition that affects up to 2% of the population in the developed world, and is linked to significant morbidity and mortality; it is therefore considered a major concern for public health. In 2014, a newly developed angiotensin receptor blocker and neprilysin inhibitor (angiotensin-receptor neprilysin inhibitor), namely sacubitril/valsartan (SAC/VAL), was introduced as a treatment for chronic HF (CHF), and it proved to have the efficacy, safety, and cost-effectiveness to improve quality of life and longevity in patients with heart failure with reduced ejection fraction and reduces hospital admission. In this review, we first summarize the current knowledge regarding HF, then provide an overview of the current knowledge on SAC/VAL for CHF, together with relevant clinical trials and future perspectives.
Publish Date 2021-08-23 13:28
Citation Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. World J Cardiol 2021; 13(8): 325-339
URL https://www.wjgnet.com/1949-8462/full/v13/i8/325.htm
DOI https://dx.doi.org/10.4330/wjc.v13.i8.325
Full Article (PDF) WJC-13-325.pdf
Full Article (Word) WJC-13-325.docx